주식회사 셀라토즈테라퓨틱스(CELLATOZTHERAPEUTICS,INC.) / CELLATOZ THERAPEUTICS, INC.
CELLATOZ THERAPEUTICS, INC.'s KOBDi Score is 65.30 as of Sep 2026, up 1.02 points since Apr 2025; it rose in 1 of the 12 monthly updates and never fell. Its position has stayed ahead of about 94% of companies in its industry.
A year earlier, in Aug 2025, its score was 64.28 and it was ahead of about 94% of companies in its industry.
| Sep 2026 | 65.30 | ahead of 94% |
| Aug 2026 | 65.30 | ahead of 94% |
| Jul 2026 | 65.30 | ahead of 94% |
| Jun 2026 | 65.30 | ahead of 95% |
| May 2026 | 65.30 | ahead of 95% |
| Apr 2026 | 65.30 | ahead of 95% |
| Mar 2026 | 65.30 | ahead of 95% |
| Feb 2026 | 65.30 | ahead of 94% |
| Dec 2025 | 65.30 | ahead of 94% |
| Aug 2025 | 64.28 | ahead of 94% |
| Jul 2025 | 64.28 | ahead of 95% |
| May 2025 | 64.28 | ahead of 95% |
| Apr 2025 | 64.28 | ahead of 95% |
| # | ||||
|---|---|---|---|---|
| 동국제약(주)기업부설연구소 | 50–99 | #77 | ||
| 주식회사 에스씨바이오 SCBIO Inc. | 30–49 | #78 | ||
| (주)듀셀 Dewcell Bio | 30–49 | #79 | ||
| (주)제넨바이오판교지점 | 30–49 | #80 | ||
| 메디쏠라 주식회사 Medisolar Co., Ltd. | 30–49 | #81 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is CELLATOZ THERAPEUTICS, INC. located?
CELLATOZ THERAPEUTICS, INC. is registered at Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, H2208, H2211, H4205, South Korea (postal code 13487).
What industry is CELLATOZ THERAPEUTICS, INC. in?
CELLATOZ THERAPEUTICS, INC. belongs to Professional, Scientific & Technical Services › Research & Development Services › Medical and pharmaceutical research and development industry.
How many employees does CELLATOZ THERAPEUTICS, INC. have?
CELLATOZ THERAPEUTICS, INC. has 50–99 employees.
What is CELLATOZ THERAPEUTICS, INC.'s KOBDi Score?
65.30 as of September 2026, ahead of about 94% of companies in its industry.
Who are CELLATOZ THERAPEUTICS, INC.'s competitors?
Similar companies include 동국제약(주)기업부설연구소, SCBIO and Dewcell Bio.

